LYNX1 CAPITAL MANAGEMENT LP purchased 0.4% of their position (6.68K shares) of KORRO BIO, INC. on the open market
Open‑market purchase worth $78.8K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/13/2026ACC: 0000902664-26-003434
10% Owner
Since Mar 2026
+6.68K
Net shares
Net buyer
$78.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
6.68K acquired
Non-Derivative Transactions2
Common stock, $0.001 par value per share
Indirect
Shares
+5.22K
Price / share
$11.40
Trade value
$59.53K
% of position
0.3%
8/6/2026
1.54M→1.54M
Common stock, $0.001 par value per share
Indirect
Shares
+1.46K
Price / share
$13.19
Trade value
$19.28K
% of position
0.1%
8/10/2026
1.54M→1.54M
Total
Net shares
+6.68K
Net value
$78.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.001 par value per share Indirect | 8/6/2026 | P · Purchase | +5.22K | $11.40 | $59.53K | 0.3% | 1.54M | 1.54M |
| Common stock, $0.001 par value per share Indirect | 8/10/2026 | P · Purchase | +1.46K | $13.19 | $19.28K | 0.1% | 1.54M | 1.54M |
| Total | +6.68K | $78.81K | ||||||
Derivative Transactions0
No derivative transactions reported